Main Article Content
Over-recruitment, uncontrolled activation and defective removal of inflammatory
Cells (especially neutrophil and eosinophil granulocytes) from inflammatory loci
Likely play a prominent role in the development of chronic inflammatory conditions
Such as rheumatoid arthritis and asthma. During resolution of inflammation
Granulocytes undergo apoptosis thereby allowing their recognition and clearance by
Phagocytes using mechanisms that down-modulate the inflammatory response.
Although there is little doubt that apoptosis plays a critical role in embryological
Morphogenesis and tissue remodeling, it’s precise role in inflammatory disease is
Still unclear, Evidence will be presented showing that inflammatory mediators and
Pharmacological agents can differentially modulate neutrophil and eosinophil
Apoptosis and alter macrophage phagocytosis of apoptotic cells. For example, we
Believe that the powerful anti-inflammatory glucocorticoids may be using the above
Processes to selectively induce eosinophil (as well as lymphocyte) apoptosis and
Importantly enhance the clearance of the apoptotic cells. Thus the hypothesis that
Selective induction of neutrophil or eosinophil apoptosis and augmented non-
Phlogistic removal of apoptotic granulocytes by phagocytes as a potential therapeutic
Target will be discussed.
Upon acceptance of an article, the Pharmacological and Therapeutic Society of Thailand will have exclusive right to publish and distribute the article in all forms and media and grant rights to others. Authors have rights to use and share their own published articles.